Personalized Approach to the Surgical Treatment of Benign Prostatic Hyperplasia by Bipolar Transurethral Resection of the Prostate
https://doi.org/10.24060/2076-3093-2023-13-2-125-130
Abstract
Aim: to improve the outcomes of surgical treatment of benign prostatic hyperplasia by bipolar transurethral prostatic resection based on the personalized approach.
Materials and methods. Surgical treatment of prostatic hyperplasia by bipolar transurethral resection of the prostate was carried out in 50 patients: the personalized approach, that is extensive preoperative preparation, was adopted in 25 cases, and the standard procedure was implemented in the rest 25 cases. Functional outcomes were assessed in 1, 3 and 6 months aft er surgery, taking into account intra- and postoperative complications.
Results and discussion. The use of the personalized approach resulted in the reduction in the duration of surgery (p = 0.019), amount of blood loss (p = 0.027), incidence of hyperthermia in the early postoperative period (p = 0.021), duration of bladder catheterization (p = 0.030) and the duration of hospital stay (p = 0.031). The personalized approach was proved to have a positive eff ect on the functional outcome of bipolar transurethral resection of the prostate: Qmax value in 1, 3 and 6 months (p = 0.037, p = 0.030, p = 0.036), IPSS score in 6 months (p = 0.037), QOL score in 1 and 3 months (p = 0.041, p = 0.030) and residual urine volume in 3 and 6 months (p = 0.035, p = 0.040).
Conclusions. Th e personalized approach contributes to improving the functional outcomes of bipolar transurethral resection of the prostate, namely, improving the Qmax value in 1, 3 and 6 months, reducing the IPSS score in 6 months and the QOL score in 1 and 3 months, and decreasing the residual urine volume in 3 and 6 months.
Keywords
prostatic hyperplasia,
bipolar transurethral resection of the prostate,
preoperative management,
postoperative complications,
personalized approach,
persistent irritative symptoms,
alpha-blockers,
anticholinergics
Supporting agencies: This work is not funded
About the Authors
I. A. Chekhonatskii
Russian Medical Academy of Postgraduate Education
Russian Federation
Russian Federation
Iliya A. Chekhonatskii
Department of Urology and Andrology Surgery
Moscow
O. B. Loran
Russian Medical Academy of Postgraduate Education
Russian Federation
Russian Federation
Oleg B. Loran, Dr. Sci. (Med.), Prof., Academician of the Russian Academy of Sciences
Department of Urology and Andrology Surgery
Moscow
References
1. Chehonackiy I. A., Loran O. B., Lukianov I. V., Seregin A. V., Morozov A. D. Intravesical prostatic protrusion as a predictor of the functional outcome of surgical treatment of benign prostatic hyperplasia. Urologiya. 2022; 3: 58–62 (In Russ.). DOI: 10.18565/urology.2022.3.58-62
2. Alyaev Yu. G., Rapoport L. M., Vinarov A. Z., Tsarichenko D. G., Fiev D. N., Bushuev V. O. Large prostate hyperplasia preoperative preparation and treatment features. Andrology and Genital Surgery. 2009; 10 (1): 50–3 (In Russ.).
3. Ergakov D. V., Martov A. G., Turin D. E., Andronov A. S. Lower urinary tract symptoms after transurethral resection of the prostate. Urologiya. 2020; (1): 103–9 (In Russ.). DOI: 10.18565/urology.2020.1.103-109
4. Loran O. B., Chekhonatsky I. A., Lukyanov I. V. Evaluation of the effectiveness of endoscopic methods for surgical treatment of benign prostatic hyperplasia based on the results of international meta-analyses data (review). Saratov Journal of Medical Scientific Research. 2021; 17 (2): 209–13 (In Russ.).
5. Pushkar D. Yu., Rasner P. I., Aboyan I. A., Asfandiyarov F. R., Kotov S. V., Kogan M. I., et al. “LUTS/BPH — who treats?” Th e results of the epidemiologic study. Urologiya. 2019; 1: 5–15 (In Russ.). DOI: 10.18565/urology.2019.16.5-15
6. Deng Y., Zheng Z., Cheng S., Lin Y., Wang D., Yin P., et al. The factors associated with nosocomial infection in elderly hip fracture patients: gender, age, and comorbidity. Int Orthop. 2021; 45 (12): 3201–9. DOI: 10.1007/s00264-021-05104-3
7. Tan Y. G., Teo J. S., Kuo T. L. C., Guo L., Shi L., Shutchaidat V., et al. A systemic review and meta-analysis of transabdominal intravesical prostatic protrusion assessment in determining bladder outlet obstruction and unsuccessful trial without catheter. Eur Urol Focus. 2022; 8 (4): 1003–14. DOI: 10.1016/j.euf.2021.09.016
8. Martov A. G., Turin D. E., Ergakov D. V., Andronov A. S., Kamalov A. A. Selection of drug therapy in patients aft er bipolar transurethral resection of the prostate depending on its original size. Experimental and Clinical Urology. 2019; 2: 70–9 (In Russ.). DOI: 10.29188/2222-8543-2019-11-2-70-78
9. Ergakov D. V., Martov A. G. Combination therapy in the management of urinary disorders after transurethral resection of the prostate. Urologiya. 2018; 1: 62–70 (In Russ.). DOI: 10.18565/urology.2018.1.62-70
10. Tsukanov A. Yu., Akhmetov D. S., Novikov A.A., Negrov D.A., Putintseva A. R. Prevention of encrustation and biofilm formation on the ureteral stent surface. Part 1. Experimental and Clinical Urology. 2020; 3: 176–81 (In Russ.). DOI: 10.29188/2222-8543-2020-12-3-176-181
11. Serlin D. C., Heidelbaugh J. J., Stoffel J. T. Urinary retention in adults: evaluation and initial management. Am Fam Physician. 2018; 98 (8): 496–503. PMID: 30277739.
12. He Y. L., Chen Y., Wen Y. B., Zhai R. Q., Ma Y., Wang J. J., et al. Changes in bladder function with time following cystostomy in rats. Neurourol Urodyn. 2020; 39 (2): 565–75. DOI: 10.1002/nau.24241
13. Forsvall A., Jönsson H., Wagenius M., Bratt O., Linder A. Rate and characteristics of infection after transrectal prostate biopsy: a retrospective observational study. Scand J Urol. 2021; 55 (4): 317–23. DOI: 10.1080/21681805.2021.1933169
14. Ergakov D. V., Martov A. G., Asliev K. A. Clinical use of cytomedin in patients with prostate diseases. Experimental and Clinical Urology. 2021; 14 (3): 136–40 (In Russ.). DOI: 10.29188/2222-8543-2021-14-3-136-140
15. Grigoriev N. A., Abdullin I. I., Loginov A. V., Zhilyaev E. V. Fosfomycin in antibiotic prophylaxis of infectious complications after biopsy of the prostate. Meditsinskiy sovet = Medical Council. 2022; 6: 68–73 (In Russ.). DOI: 10.21518/2079-701X-2022-16-6-68-73
Review
For citations:
Chekhonatskii I.A., Loran O.B. Personalized Approach to the Surgical Treatment of Benign Prostatic Hyperplasia by Bipolar Transurethral Resection of the Prostate. Creative surgery and oncology. 2023;13(2):125-130. (In Russ.) https://doi.org/10.24060/2076-3093-2023-13-2-125-130
Views:
498
Email this article 